The antibiotic delafloxacin emerges as a potential therapeutic alternative against Legionella
A study led by IGTP researchers shows that, in a laboratory model, delafloxacin inhibits the intracellular replication of Legionella more effectively than a current standard treatment, supporting its potential therapeutic value and the need for future clinical studies.